跳至主要内容
临床试验/NCT02267798
NCT02267798已完成不适用

The Effects of Repetitive Arm Training Combined With Functional Electrical Stimulation on Upper Extremity Motor Recovery in Sub-acute Stroke Survivors

University Hospital of Ferrara4 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2013年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
64
试验地点
4
主要终点
Changes from baseline in Fugl-Meyer Upper Extremity (FM-UE)

研究概览

简要总结

Rehabilitation restores functions and reduces disabilities due to diseases sequelae. The relationship between intensity of rehabilitation and clinical outcomes, recently emphasized, has generated a great interest for technological high-intensity interventions. However, their effects compared to traditional interventions as well the involved biological mechanisms remain uncertain. The present Strategic Program aims to predict the treatment efficacy in specific rehabilitation profiles, to improve the use of "targeted" therapies and the individual management of patients affected by stroke and to transfer these findings into rehabilitative strategies.

详细描述

Primary endpoint: Fugl-Meyer Upper Extremity (FM-UE) Secondary endpoints: Box and Block Test (BBT), Modified Ashworth Scale (MAS); motor cortex excitability (TMS); Electromyography analysis of muscle activation patterns during upper extremity movements; measurements of cerebral perfusion (NIRS); circulating biomarkers (see Figure 3 and Table 1). Overall assessments will be performed pre-, mid-, post-treatment and at 6-months follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • males and females, age 18 to 79 years
  • diagnosis of first, single unilateral ischemic stroke verified by brain imaging < 8 weeks
  • upper limb motor function defined by an FM-UE score > 11 and <55

排除标准

  • medical conditions likely to interfere with the ability to safely complete the study protocol
  • impaired cognitive functioning: score less than 24 on the Mini Mental Status Examination (MMSE)
  • severe upper-limb pain, referred as > 7 at Visual Analog Scale (VAS)
  • history of seizures or epilepsy

结局指标

主要结局

Changes from baseline in Fugl-Meyer Upper Extremity (FM-UE)

时间窗: 1) One week prior to treatment initiation 2) after 3 weeks 3) the week after the end of treatment 4) at 6 months follow-up.

Measure of upper extremity motor impairment. The upper extremity score ranges from 0-66.

次要结局

  • Wolf Motor Function Test (WMFT) Manual(1) One week prior to treatment initiation 2) after 3 weeks 3) the week after the end of treatment 4) at 6 months follow-up)
  • Modified Ashworth Scale (MAS)for spasticity measure(1) One week prior to treatment initiation 2) after 3 weeks 3) the week after the end of treatment 4) at 6 months follow-up)
  • Motor Activity Log (MAL)measures change in arm use during activities of daily living(1) One week prior to treatment initiation 2) after 3 weeks 3) the week after the end of treatment 4) at 6 months follow-up)
  • Box and Block test(1) One week prior to treatment initiation 2) after 3 weeks 3) the week after the end of treatment 4) at 6 months follow-up)
  • Analysis of muscle activation patterns during upper extremity movements(1) One week prior to treatment initiation 2) the week after the end of treatment 3) at 6 months follow-up)
  • NIRS (Near Infrared Spectroscopy)(1) One week prior to treatment initiation 2) after 3 weeks 3) the week after the end of treatment 4) at 6 months follow-up)
  • Functional Independence Measure (FIM)(1) One week prior to treatment initiation 2) after 3 weeks 3) the week after the end of treatment 4) at 6 months follow-up)
  • Stroke Impact Scale 3.0 (SIS)(1) One week prior to treatment initiation 2) after 3 weeks 3) the week after the end of treatment 4) at 6 months follow-up)
  • Motor cortex excitability (single pulse and paired pulse TMS)(1) One week prior to treatment initiation 2) after 3 weeks 3) the week after the end of treatment 4) at 6 months follow-up)
  • Circulating Biomarkers(1) One week prior to treatment initiation 2) after 3 weeks 3) the week after the end of treatment 4) at 6 months follow-up)

研究者

发起方
University Hospital of Ferrara
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sofia Straudi, MD

MD

University Hospital of Ferrara

研究点 (4)

Loading locations...

相似试验